David J. Porter
2 Park Road
Grafton, AUK 1023, New Zealand
Grafton, AUK 1023, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell death.
Journal: Acta biomaterialia
Published: February 18, 2026
A cancer stem cell-directed nano-chemotherapy enhances anti-PD-L1 immunotherapy in breast cancer by inducing immunogenic cell death.
Journal: Acta biomaterialia
Published: February 18, 2026
A pH-sensitive nanococktail enabled cancer stem cell elimination, deep tumour penetration, and tumour shrinkage.
Journal: International journal of pharmaceutics
Published: February 10, 2026
Palbociclib for Hormone-Receptor-Positive, HER2-Positive Advanced Breast Cancer.
Journal: The New England journal of medicine
Published: January 28, 2026
A thymine-challenge test to prospectively evaluate dihydropyrimidine dehydrogenase activity for risk of severe 5-fluorouracil-induced gastrointestinal toxicity.
Journal: Cancer chemotherapy and pharmacology
Published: April 30, 2025
The younger women's wellness after cancer program: results from feasibility testing in Aotearoa New Zealand (the 'Kōwhai study').
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: July 04, 2024
Liposome-enabled bufalin and doxorubicin combination therapy for trastuzumab-resistant breast cancer with a focus on cancer stem cells.
Journal: Journal of liposome research
Published: January 25, 2024
Stability of trastuzumab during nanomedicine formulation using SEC-HPLC coupled with polyacrylamide gel electrophoresis.
Journal: Pharmaceutical development and technology
Published: March 13, 2023
Testing for dihydropyrimidine dehydrogenase deficiency in New Zealand to improve the safe use of 5-fluorouracil and capecitabine in cancer patients.
Journal: The New Zealand medical journal
Published: November 17, 2021
Protocol of trans-Tasman feasibility randomised controlled trial of the Younger Women's Wellness After Breast Cancer (YWWACP) lifestyle intervention.
Journal: Pilot and feasibility studies
Published: October 15, 2021
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity?
Journal: European journal of drug metabolism and pharmacokinetics
Published: September 09, 2021
Cyclophosphamide bioactivation pharmacogenetics in breast cancer patients.
Journal: Cancer chemotherapy and pharmacology
Published: February 28, 2021
Last Updated: 09/26/2026